Afatinib in first-line setting for NSCLC harbouring common EGFR mutations: new light after the preliminary results of LUX-Lung 7?
[摘要]
[发布日期] [发布机构]
[效力级别] [学科分类] 呼吸医学
[关键词] Non-small cell lung cancer (NSCLC);epidermal growth factor receptor (EGFR);afatinib;common mutations;LUX-Lung 7 (LL7) [时效性]
